DKBmed Podcasts

•

Channel • 5 Shows

Medicine

Medicine

Updated Monthly
Medicine

Medicine

Updated Weekly
Medicine

Medicine

Updated Weekly
Medicine

Medicine

Updated Monthly
Medicine

Medicine

Updated Monthly

01/17/2025

Promising New Options in MS Care

The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future. Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/219/test) Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/216) Hosted on Acast. See acast.com/privacy for more information.

01/17/2025

•

23 min
JAN 22

Dialogues in Obesity: Where Visionaries Meet to Lead the Change

Episode 2: The Role of Pharmacotherapy for Treatment of Obesity Hosted on Acast. See acast.com/privacy for more information.

Jan 22

•

39 min
02/25/2019

Clinical Markers for MS Diagnosis and Prognosis

The central vein sign. Optical coherence tomography. Serum neurofilament light chain. New research has identified these markers as valuable in discriminating MS from mimicking conditions, and in predicting future disability. In this Issue, Dr. Michael Kornberg and Dr. Elias Sotirchos from the Johns Hopkins University School of Medicine discuss how these advances can impact clinical decision-making to provide better patient care. Take our post-test to claim CME credits. To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.

02/25/2019

•

27 min
09/17/2024

POMS: A Clinical View

In this issue: POMS. Pediatric Onset Multiple Sclerosis: children and adolescents with symptoms indicating a diagnosis of multiple sclerosis. Are their presentations different from adult-onset MS? POMS is often associated with higher degrees of activity and inflammation early in the disease. How can clinicians most effectively confirm an early MS diagnosis in these young patients? What does the current evidence show about when to prescribe high-efficacy disease modifying therapies? What activity limitations should be placed on patients with POMS? Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/209/test) Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/208) Hosted on Acast. See acast.com/privacy for more information.

09/17/2024

•

26 min
03/10/2021

Clinical Approaches and DMT Choices

As the number of new MS therapies continues to grow, so does the uncertainty about which management approach — escalation or highly effective disease-modifying therapy — is best for each patient. What are the patient-specific factors that indicate the most appropriate DMT selection? What’s known about the potential longer-term risks associated with highly effective therapies? That’s the focus of our discussion with Dr. Yujie Wang from the University of Washington and Johns Hopkins University, and Dr. Anne Damian-Yacoub from Johns Hopkins University in this eMultipleSclerosis Review podcast. Take our post-test to claim CME credits. To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.

03/10/2021

•

23 min
02/11/2025

Treating Sexual & Bladder Dysfunction in Patients with MS

The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future. Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/222/test) Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/218) Hosted on Acast. See acast.com/privacy for more information.

02/11/2025

•

30 min
11/22/2023

Emerging MS Clinical Options

Has the place for BTK inhibitors in MS been determined? How well do extended interval or alternative B cell depletion dosing regimens work, and for which patients? Do the data support HSCT (hematopoietic stem cell transplant) over high-efficacy DMT — again, for which patients, and with what efficacy and safety? Join us, as guest host Dr. Cole Harrington from the Ohio State University explores these important topics in this issue of eMultipleSclerosis Review. Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/178/test) Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/176) Hosted on Acast. See acast.com/privacy for more information.

11/22/2023

•

24 min
12/11/2025

Dialogues in Obesity: Where Visionaries Meet to Lead the Change

Episode 1: Obesity as a Chronic Disease Hosted on Acast. See acast.com/privacy for more information.

12/11/2025

•

32 min
02/11/2025

Treating Sexual & Bladder Dysfunction in Patients with MS

The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future. Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/222/test) Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/218) Hosted on Acast. See acast.com/privacy for more information.

02/11/2025

•

30 min
09/14/2022

ETI (CFTR Triple Therapy): Clinical Opportunities

The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three agents really better than two? For which patients, in what circumstances? What does the CF Team need to understand to ensure their patients get maximum benefit? Join us as we explore these questions with guest author Professor Edward McKone MD, from St. Vincent’s University Hospital and University College Dublin School of Medicine, in this eCysticFibrosis Review podcast. Take our post-test to claim CME credits. Read this podcast's companion newsletter here. Hosted on Acast. See acast.com/privacy for more information.

09/14/2022

•

28 min

Free CME/CE podcasts for health care providers presented by DKBmed. Physicians, Nurses, PAs, and other health care providers can earn free CME/CE credit simply by listening to these podcasts and completing the post-test in the description.

Website

DKBmed Podcasts

Top Shows

Promising New Options in MS Care

Dialogues in Obesity: Where Visionaries Meet to Lead the Change

Clinical Markers for MS Diagnosis and Prognosis

POMS: A Clinical View

Clinical Approaches and DMT Choices

Treating Sexual & Bladder Dysfunction in Patients with MS

Emerging MS Clinical Options

Dialogues in Obesity: Where Visionaries Meet to Lead the Change

Treating Sexual & Bladder Dysfunction in Patients with MS

ETI (CFTR Triple Therapy): Clinical Opportunities

About

DKBmed Podcasts

Top Shows

Top Episodes

About